Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized trial of treatment and follow-up of vaginal intraepithelial neoplasia (VAIN)
2012-005377-31Phase 4Completed
- Sponsor
- Helsinki University Women's Hospital
- Start
- Jan 2016
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of imiquimod in vaginal intraepithelial neoplasia (VAIN), sponsored by Helsinki University Women's Hospital. Started Jan 2016; status: completed.
02
Drugs
imiquimod
03
Conditions
vaginal intraepithelial neoplasia (VAIN)
Beyond the preview
Go deeper on 2012-005377-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005377-31.